SCOTTSDALE, Ariz.--(BUSINESS WIRE)--ImmuneRegen® BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB:IRBO), announces additional study results that confirm the effects of its compound Homspera® in stimulating the development of human adult stem cells. The results, also found in earlier studies, document Homspera’s ability to enhance formation of early-stage blood cells from adult hematopoietic (blood-forming) stem cells.
